The mTOR inhibition has been reported to reduce or prevent BBB breakdown in several models of neurological disorders, including cerebral ischemia-reperfusion injury, Alzheimer’s disease, subarachnoid hemorrhage, and status epilepticus [18, 32–37]. The gene discussed is MTOR; the disease is Alzheimer disease.